![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 34, 23893-23900, August 20, 1999
From the Institute of Enzymology, Biological Research Center,
Hungarian Academy of Sciences,
H-1518 Budapest, P. O. Box 7, Hungary
We have sequenced the cDNA of a novel
Ca2+-activated cysteine proteinase (calpain) from the
fruit fly, Drosophila melanogaster. The predicted protein,
designated as CALPB, shows high similarity to the previously identified
Drosophila calpain, CALPA. The two proteins were expressed
in Escherichia coli and purified to homogeneity by
metal-chelate affinity chromatography either from inclusion bodies or
from the bacterial cytosol. Both enzymes were
Ca2+-dependent proteinases and attained
half-maximal activation in the presence of millimolar Ca2+.
The activity and the rate of activation of CALPA, but not CALPB, could
be activated by phosphatidylinositol 4,5-diphosphate,
phosphatidylinositol 4-monophosphate, phosphatidylinositol, and
phosphatidic acid. A truncated form of CALPA, lacking the
CALPA-specific unique insertion region, has also been expressed and
characterized. Although it lacked the 16-amino acid long putative
membrane-anchoring segment, its activation by phospholipids was similar
to that of the full-length CALPA protein. The enzymes undergo
N-terminal autolysis in a Ca2+-dependent manner
which was shown with CALPB to run parallel with enzyme activation.
Moreover, fully autolyzed CALPB lacked the characteristic activation
phase indicating the requirement for autolysis upon activation of this
calpain form in vitro. The analysis of the mechanism of
activation in Drosophila calpains seems to corroborate the
autolysis model of calpain activation.
The Ca2+-dependent intracellular cysteine
proteinases, calpains, are important regulators of many cellular
pathways (1, 2). Through limited proteolysis of key cellular components
they are involved in processes as distinct as nerve growth (3), muscle homeostasis (4), development (5), and memory (6). Several calpain
isoforms are known in vertebrates including the ubiquitous µ- and
m-calpain and some tissue-specific isoforms, e.g. p94
(CAPN3, nCL-1)1 (7), nCL-2
(8), and nCL-4 (9). While tissue-specific isoforms seem to be
monomeric, ubiquitous calpains are associated with a small or
regulatory subunit. Invertebrate calpain homologs have also been
described, including a Schistosoma mansoni calpain (10, 11),
an atypical form in Caenorhabditis elegans (12) and a
Drosophila melanogaster calpain, CALPA (5, 13). The latter
organism is particularly important in the study of
Ca2+-regulated calpains, since C. elegans, which
is equally accessible to genetic manipulations, seems to lack the
typical, Ca2+-dependent calpains (14).
Therefore the fruit fly as a model organism is a prime candidate in the
attempt to clarify the role of calpains in vivo.
The finding of Drosophila CALPA was preceded by biochemical
studies which revealed the existence of at least two calpain isoforms in the fruit fly (15). Another calpain isoform, CANP (probably distinct
from the two partially purified ones), has been purified to homogeneity
(16). However, none of the genes encoding these proteins have yet been
found. The only Drosophila calpain cDNA cloned so far is
coding for the CALPA protein (5, 13). The protein is expressed in a few
tissues, including some cells in the brain, midgut, and embryo. It
carries a unique insertion sequence in the calmodulin-like domain with
a 16-amino acid long putative membrane-anchoring region in it.
Otherwise, its domain structure (domain I, regulatory propeptide;
domain II, Cys-protease; domain III, putative regulatory; domain IV,
Ca2+ binding) and sequence are similar to that of
conventional vertebrate calpains except for the N-terminal region of
domain I which shows no homology to any other protein sequence. No
small subunit, associated with CALPA or the purified CANP protein has
been found in line with evolutionary studies which suggest the lack of
the small subunit from protostomes (17). The CALPA protein has been
expressed in E. coli and purified partially, and some of its
possible in vivo substrates have been identified (18).
However, apart from these studies, no biochemical data are available on
the mechanism of action of Drosophila calpains with known sequences.
Here we describe the sequence of a novel fruit fly calpain, CALPB, and
the bacterial expression, purification, and enzymological characterization of Drosophila CALPA and CALPB. The
recombinant proteins worked as active,
Ca2+-dependent proteinases. A detailed study is
presented on the activation, autolysis, and lipid dependence of these
proteins. The parallel nature of the enzymes' autolysis and activation
and the lack of the activation period in the fully autolyzed enzyme
provide insights into the mechanism of calpain activation.
Materials and General Methods--
All chemicals were obtained
from Sigma. Restriction enzymes were purchased from Promega and Sigma.
Site-directed mutagenesis was carried out using a Unique Site
Elimination kit from Amersham Pharmacia Biotech, following the
instructions of the supplier. The pET-22b(+) vector and
Escherichia coli BL21 (DE3) were obtained from Novagen. The
Ni-NTA resin was purchased from Qiagen. SDS-polyacrylamide gel
electrophoresis was carried out according to Laemmli (19). Recombinant
m-calpain was prepared using the pET-24d-80k-CHis6 and the
pACpET-24 expression vectors generously provided by John S. Elce
(Department of Biochemistry, Queen's University, Kingston, Ontario,
Canada) as described in Ref. 20. The Drosophila CalpA cDNAs, corresponding to the long and the short alternative
transcript, were the same as described in Ref. 13. f28 is coding
for the short, and f32 for a partial long CALPA form. The 5'-end is
identical in the two in vivo transcripts, the f32 clone is,
however, a 5'-truncated partial clone.
DNA Sequencing--
The partial sequence (525 base pairs) of a
D. melanogaster clone from the EST data base showed
similarity to the 5'-end of Drosophila CalpA (GenBank
accession number Z46891). The clone was purchased from the I.M.A.G.E.
Consortium (Clone ID LD18261; GenBank accession number AA538677) (21),
and its complete nucleotide sequence has been determined using partial
clones generated by restriction digestions and unique primers designed
to cover the remaining gaps. The cDNA was sequenced on both strands
using an ABI 373 DNA Sequencer (Applied Biosystems). The sequence has been deposited in the GenBank data base under GenBank accession number
AF062404. The 5'-end of the cDNA was assembled from 16 further EST
clones found in the GenBank data base (the GenBank accessions numbers
are: AA538677, AA820523, AA541102, AA803400, AA950981, AA940775,
AI239004, AA951075, AA951990, AA820314, AA979265, AA820721, AA202961, AA536318, AA539598, AA539124). The identity of the starting Met was
confirmed by all of the EST clones overlapping in this region
(AA820523, AA950981, AI239004, AA940775, AA951990, AA202961, AA539598,
AA820721, and AA820314). These all carried an in-frame stop codon
before the starting Met. The identified open reading frame coded for a
novel Drosophila calpain, CALPB.
N-terminal Sequence Analysis--
The samples were run on SDS
gels and blotted onto polyvinylidene difluoride membranes (Sigma) for
120 min, at 250 mA in a buffer containing 10 mM CAPS, pH
11, and 10% methanol. Sequence analysis was performed on a
Perkin-Elmer ABI 471A pulsed-liquid phase sequencer equipped with
on-line Perkin-Elmer ABI 120 PTH analyzer and Kipp and Zonen dual-pen
strip chart recorder (type BD 41). The polyvinylidene difluoride-bound
proteins were sequenced employing a modified Edman degradation
sequencer program.
Construction of Expression Vectors--
The f28 clone,
containing the short transcript of the CalpA gene, and the f32 clone,
containing the long transcript truncated at the 5'-end, were ligated at
a BamHI site to obtain the f28-32 clone with a
full-length CALPA open reading frame. A frameshift mutation, present in
the f32 clone was replaced with the corresponding region in f28
using PvuI sites. The open reading frame from the f28-32 clone was amplified with the
CATGAATTCACATATGGACGACTTGAGGG and CATAGTCGACCGAATATATTGTGCGCTC primers
using proofreading Pfu polymerase (Stratagene). The
amplified fragment was digested with NdeI-SalI
and ligated into the NdeI-XhoI sites of the
pET-22b(+) expression vector. The ligation region of the resulting
CALPA-pET-22b vector (Fig. 1A)
was checked by sequencing.
The region containing the CALPB open reading frame in the LD18261 clone
was amplified using the GCCTATTCTAGACATATGCCCTATCCAACTGGCATG and
ATATCTAGATCTCGAGAGAGTAAATTGTTCGCTCCAGCC primers. Since Pfu polymerase yielded insufficient product, this clone was amplified using
Taq polymerase. The polymerase chain reaction product was digested with NdeI-XhoI and ligated into the
NdeI-XhoI sites of the pET-22b(+) expression
vector. The ligation region of the resulting CALPB-pET-22b (Fig.
1B) vector was checked by sequencing.
Site-directed Mutagenesis of CALPA-pET-22b--
A mutant form of
CALPA, lacking the inserted region, has also been created via
site-directed mutagenesis. The primers
TTGGAGAAACGGTTGGGTACCACTGGTTTGGGTAAATC and
GAGTCTCATCCACAGGTACCTTTGCTGTTACAGG were used in a Unique Site Elimination (U.S.E.) strategy (Amersham Pharmacia Biotech), carried out
according to the manufacturer's instruction. KpnI sites
were introduced at the 5'- and 3'-end of the inserted region. The
mutated plasmid was cut with KpnI and ligated. The identity
of the mutations and the ligation site have been verified by
sequencing. The resulting plasmid is referred to as
CALPA- Calpain Preparation--
The E. coli strain BL21(DE3)
was transformed with the expression vectors using conventional
techniques. Cells were grown in NZYM media containing ampicillin (100 µg/ml) at 37 °C, 250 rpm, until OD600 0.7-1.0. The
expression of recombinant CALPA was induced by the addition of
isopropyl-1-thio-
The CALPA- Caseinolytic Assay--
The activity of calpain was measured in
a caseinolytic assay as described in Ref. 16.
Fluorometric Assay--
Calpain activity was also measured in a
continuous fluorometric assay in a JASCO FP 777 spectrofluorometer. The
cleavage of the fluorescent substrate,
N-succinyl-Leu-Tyr-7-amino-4-methyl-coumarin (Sigma), was
recorded. The excitation wavelength was 380 nm and light emitted at 460 nm was monitored. Reactions were set up in a final volume of 50 µl at
room temperature in calpain puffer. Calpains were added in a final
concentration of 0.1-0.3 mg/ml, the concentration of the fluorescent
substrate was 1 mM and, where needed, phospholipids were
added at a final concentration of 50 µg/ml. The reaction was started
by the addition of CaCl2.
Autolysis of Calpains--
Autolysis of calpains was followed
under conditions identical to those of the flurometric assay. The
reaction was started by CaCl2 and stopped by the addition
of SDS sample buffer and immediate boiling for 2 min. The samples were
analyzed on SDS-polyacrylamide gel electrophoresis using Coomassie
Brilliant Blue staining. Band intensities were determined by
densitometry in a Bio-Rad GelDoc 1000 video densitometer. The linear
relationship of optical densities and protein quantity was checked by calibration.
Sequence of Drosophila CALPB--
The LD18261 clone contained an
open reading frame encoding a 791-amino acid polypeptide with a
predicted molecular mass of 90,134 daltons. The first ATG was assigned
to be the initiation codon. Although we cannot yet exclude the
possibility that the natural protein has further N-terminal amino
acids, the identity of the start site was corroborated by the
occurrence of a 5' in-frame stop codon in all of the overlapping EST
clones. A polyadenylation signal was found within the 3'-untranslated
region. The new predicted Drosophila calpain homolog,
designated as CALPB, has a domain structure similar to that of
vertebrate calpains and shows highest similarity to the CALPA protein
(13). However, the N-terminal ends of the two proteins are unrelated,
and the unique insertion sequence present in domain IV of CALPA is
absent from CALPB (Fig. 2). The
homologous region of the sequences shows 78% amino acid identity.
CALPB carries the conserved Cys, His, and Asn active site residues,
characteristic of papain-like cysteine proteases, and six putative
Ca2+-binding EF-hand motifs (Fig. 2).
To study the relationship of CALPB to vertebrate calpains, a
phylogenetic tree was constructed from some representative calpain homologs and Drosophila calpains (Fig.
3). The position of CALPA and CALPB in
the tree suggests that separation of these isoforms occurred later than
the divergence of the ancestors of vertebrates and insects, therefore
these two fruit fly paralogs have no direct counterpart in
vertebrates.
Purification and Specific Activity of CALPA, CALPA- Ca2+ Dependence and the Effect of Other
Divalent Cations--
Both CALPA and CALPB attained maximal activity
in the millimolar calcium range (Fig. 4).
The calcium concentration required for half-maximal activity was
2.18 ± 0.46 for CALPA, 3.23 ± 0.23 mM for
CALPA- Autolysis of Calpains--
Fig. 5
shows the autolytic conversion of CALPA, CALPA-
The 81-kDa autolytic fragment of CALPA-
Vertebrate µ- and m-calpains were shown to become more sensitive to
calcium after autolysis (23, 24). This, however, was not the case for
CALPB. Fully autolyzed CALPB showed half-maximal activity in the
millimolar range, at 4.54 ± 0.56 mM free
Ca2+. CALPA and CALPA- Activation of Calpains--
The activation of CALPA, CALPA- The Relation of Autolysis and Activation in CALPB--
Activation
of CALPB ran parallel with its autolysis as shown in Fig.
8. This parallelism and the unusually
long activation periods hint at the necessity of autoprocessing before
conversion of the substrate is made possible. To test the hypothesis
that autolysis is a prerequisite for, and not a consequence of,
activation, CALPB was fully autolyzed, dialyzed against calpain puffer,
and assayed in the fluorometric test (Fig.
9). In this case no activation period
could be observed, even at low Ca2+ concentrations,
indicating that, in contrast to the intact protein, the autolyzed form
becomes fully active right after the addition of calcium.
Similar measurements could not be carried out with CALPA and
CALPA- The Effect of Phospholipids--
Vertebrate calpains have been
shown to be activated by certain phospholipids. The occurrence of CALPA
immunoreactivity in the 100,000 × g pellet in
cell-fractionation experiments (data not shown) and the presence of a
16-amino acid long hydrophobic segment in the primary structure of
CALPA pointed to its possible regulation by membrane lipids. These led
us to measure the effect of various phospholipids on the activity and
activation rate constant (first-order rate constant of activation) of
our recombinant enzymes. The activation rate constant is the reciprocal
of transit time if we assume that activation can be described by a
first-order reaction (25).
The activity and activation rate constant of CALPA and CALPA- CALPB, a New Drosophila Calpain--
The new homolog, reported
here, is the second known protein in Drosophila which
belongs to the canonical, Ca2+-regulated calpains. It has
been expressed, along with CALPA and a mutant form of CALPA, in
E. coli, and purified to homogeneity. Active CALPA could be
produced using a denaturation step, similarly to recombinant human
µ-calpain (26), while CALPB and CALPA- Calpain Activation--
The study of these enzymes can contribute
to the elucidation of regulatory mechanisms in calpains which has been
controversial for a long time (1, 28-30). One of the widely accepted
models claims that calpains become active through N-terminal autolysis (31, 32). The alternative view holds that intact calpain is the active
form (33, 34), and autolysis is only responsible for the dissociation
of the enzyme from the plasma membrane (35, 36), for fine-tuning
substrate specificity (37) or subunit dissociation (30, 38). The
parallel nature of autolysis and activation in Drosophila
CALPB and the lack of an activation phase in the fully autolyzed enzyme
argue for the necessity of autolysis in Drosophila calpain
activation in vitro. The almost identical position of the
self-cleavage site in vertebrate and the fruit fly calpains reflects
conserved structural features even in the sequentially unrelated
N-terminal region. This conservation indicates functional constraints
and therefore the characteristics of autolysis in Drosophila
calpains point to similar regulation in the vertebrate enzymes. The
apparent difference is that the Ca2+ requirement of CALPB
is not reduced upon autolysis. In fact, it may not be autolysis that
alters Ca2+ sensitivity in vertebrate calpains either; in
the model proposed by Suzuki and co-workers it is dissociation of the
heterodimer (30, 38) that causes the increase in the enzyme's
Ca2+ sensitivity.
Ca2+ Sensitivity--
A considerable difficulty in
understanding calpain activation in vivo stems from the
unphysiologically high in vitro calcium requirement. The
high Ca2+ need of Drosophila enzymes cannot be
attributed to imperfect renaturation because soluble CALPA- Phospholipid Action--
The effect of phospholipids on calpain
activity and autolysis has been studied extensively. According to one
view calpain migrates to the plasma membrane upon Ca2+
signals (35, 43) and becomes activated by membrane lipids (39) through
a decrease in the Ca2+ concentration needed for autolysis.
The effect of phospholipids on the activity and activation rate
constant of CALPA suggests a similar regulatory mechanism. In the case
of CALPA certain phospholipids seem to cause an increase in enzyme
activity. This leads to enhanced autolysis which in turn results in the
faster activation observed. It can be shown that a change in the
Ca2+ sensitivity of autolysis (indirect kinetic parameter)
can result from increased specific activity and activation rate
constant (direct kinetic parameters) assuming similar activating effect of phospholipids at all Ca2+ concentrations. Again it is
not likely that renaturation has much altered the lipid dependence of
CALPA since soluble CALPA-
The 16-amino acid long hydrophobic stretch in the CALPA-specific
inserted region is the first obvious candidate to mediate lipid action.
However, the removal of it had only slight effect on the lipid
dependence of enzyme activity. This hydrophobic stretch is therefore
not solely responsible for lipid activation, but may probably serve as
an anchor bringing CALPA close to the membrane, and other lipid-binding
sites should exist to mediate lipid action in CALPA-
Despite the phylogenetic distance of Drosophila and
vertebrate calpains, many features of calpain activation seem to be
evolutionary conserved. The similarities in the activation, autolysis,
and lipid dependence substantiate our efforts with CALPA and CALPB as
useful models in the analysis of the calpain system, and urge us to
exploit the genetic accessibility of the fruit fly.
We are grateful to Dr. P. Tompa and A. Farkas
for helpful discussions and Klára Majzik for highly skilled and
devoted technical assistance.
*
This work was supported by grants T 17633 and T 22069 from
Hungarian National Research Fund and 96/2-417 3.3/51 from Academy Research Grant.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The abbreviations used are:
nCL-X, novel calpain
large subunit;
EST, expressed sequence tag;
2-ME, mercaptoethanol;
PI, phosphatidylinositol;
PIP, phosphatidylinositol 4-monophosphate;
PIP2, phosphatidylinositol 4,5-diphosphate;
CAPS, 3-(cyclohexylamino)propanesulfonic acid.
Characterization of Two Recombinant Drosophila
Calpains
CALPA AND A NOVEL HOMOLOG, CALPB*
and
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (24K):
[in a new window]
Fig. 1.
The cloning region of the calpain expression
vectors. A, CALPA-pET-22b; B, CALPB-pET-22b.
Rbs indicates the bacterial ribosome-binding site. The
NdeI sites used for subcloning generate the starting Met
(bold). His6 represents the C-terminal fused 6 His residues. The additional C-terminal Val and Glu residues in CALPA,
and Leu and Glu residues in CALPB derive from
SalI/XhoI and XhoI sites,
respectively. The stop codon is shown in bold.
Ins-pET-22b. This construct allowed expression of the
truncated, 87-kDa CALPA-
Ins protein, having only two residues (Val
and Pro, introduced with the KpnI sites) instead of a
72-amino acid-long region between Val620 and
Val693.
-D-galactopyranoside to a final
concentration of 0.2 mM. Incubation was continued for
3 h at 37 °C, 250 rpm. The culture was cooled on ice and
centrifuged at 3,000 × g for 20 min at 4 °C. Cells
were suspended in 100 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 20 mM 2-ME, 1 mM phenylmethylsulfonyl fluoride, 5 mM
benzamidine, 1% Triton X-100, and sonicated for 6 × 15 min at 16 µm on ice. The lysate was centrifuged at 3,000 × g
for 20 min at 4 °C. The supernatant was discarded, and the pellet
was washed with 100 mM Tris-HCl, pH 7.5, 2 M
urea, 20 mM 2-ME. Inclusion bodies were solubilized in 100 mM
NaH2PO4/Na2HPO4, pH
7.5, 8 M urea, 20 mM 2-ME, 20 mM
imidazole for 30 min at room temperature. Solubilized inclusion bodies
were diluted in 10 volumes of Ni-NTA buffer I (100 mM
NaH2PO4/Na2HPO4, pH
7.5, 6 M urea, 20 mM 2-ME, 20 mM
imidazole) and incubated overnight at 4 °C. Insoluble inclusion
bodies were removed by centrifugation at 100,000 × g
for 60 min at 4 °C. The supernatant was applied to a 10 ml of Ni-NTA
resin (Qiagen) equilibrated with Ni-NTA buffer I. The resin was washed
with 10 volumes of Ni-NTA buffer I. CALPA was eluted with a linear
gradient of imidazole from 20 to 250 mM in Ni-NTA buffer I. The calpain-containing fractions were pooled, and the protein was
refolded in calpain buffer (10 mM Hepes, pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1 mM
phenylmethylsulfonyl fluoride, 0.5 mM benzamidine, 5 mM 2-ME) containing 4, 3, 2, 1, and 0 M urea,
at least 8 h each.
Ins and CALPB proteins were purified from the soluble
fraction of E. coli. Cells were grown in the same conditions as described above. The proteins were expressed in the presence of 0.05 mM isopropyl-1-thio-
-D-galactopyranoside at
20 °C for 3 h, 250 rpm. Cells were suspended in 100 mM
NaH2PO4/Na2HPO4, pH
7.5, 150 mM NaCl, 1 mM EDTA, 20 mM
2-ME, 1 mM phenylmethylsulfonyl fluoride, 5 mM
benzamidine, and sonicated for 6 × 15 min at 16 µm on ice. The
lysate was centrifuged at 100,000 × g for 60 min at
4 °C and the supernatant was applied to the Ni-NTA column. After
washing with 10 column volumes of Ni-NTA buffer II (100 mM
NaH2PO4/Na2HPO4, pH
7.5, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 5 mM benzamidine, 20 mM 2-ME)
containing 20 mM imidazole, native calpains were eluted
with a linear gradient of 20-250 mM imidazole in Ni-NTA
buffer II. To prepare CALPB from inclusion bodies,
isopropyl-1-thio-
-D-galactopyranoside was added to a final concentration of 1 mM and protein was expressed for
3 h at 37 °C, 250 rpm. The purification of CALPB from inclusion
bodies was done in the same way as preparation of CALPA. Unless
otherwise indicated, CALPB refers to the enzyme prepared from the
bacterial cytosol.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (52K):
[in a new window]
Fig. 2.
Alignment of Drosophila
CALPA and CALPB. The two sequences have dissimilar N
termini, and the CALPA-specific unique insertion sequence is absent
from CALPB. Identical and conserved residues are in a black
box. The active site residues are marked with an asterisk.
Arrows point to the site of autolysis, arrowheads
indicate the deleted region in the CALPA-
Ins construct (see main
text). The calcium-binding loop of potential EF-hands is
underlined. The hydrophobic stretch in the CALPA-specific
insert is in a white box.

View larger version (11K):
[in a new window]
Fig. 3.
Phylogenetic relationship of
Drosophila CALPA and CALPB to
Ca2+-regulated vertebrate calpains. The GenBank
accession numbers are in parentheses. The tree was generated from a
ClustalW alignment of human µ- (X04366), human m-calpain (M23254),
human nCL-1 (X85030), human nCL-4 (AF022799), rat nCL-2 (D14478),
chicken µ/m-calpain (X01415), C. elegans YKR2 (L25598),
D. melanogaster CALPA (Z46891), CALPB (AF062404), and
S. mansoni calpain (M74233) using the Seqboot, Protdist,
Neighbor, and Consense programs from the Phylip package (44). Bootstrap
values of 100 pseudoreplicates are shown at the nodes of the tree.
Schistosoma calpain served as an outgroup. The tree does not
include all known calpain sequences, but one from each vertebrate
subfamily, excluding atypical vertebrate and deeply branching
invertebrate ones. The scale represents 0.1 distance units as
determined with the categories model (44).
Ins, and
CALPB--
The plasmid constructs allowed the production of
recombinant CALPA, CALPA-
Ins, and CALPB fused at their C terminus
with a 6-His affinity tag. While most of recombinant CALPA was found in
insoluble aggregates, CALPA-
Ins and CALPB could be purified from the
bacterial cytosol in sufficient quantities. CALPA was purified from
inclusion bodies using a denaturation step in 8 M urea.
When expressed at higher temperature in the presence of 1 mM isopropyl-1-thio-
-D-galactopyranoside,
CALPB also formed inclusion bodies which were treated similarly to be
able to compare the effect of the different protocols. All three
enzymes were purified on a metal-chelate affinity resin which yielded
highly pure proteins (see below, Fig. 5). Only the eluted fractions
containing CALPA-
Ins contained two contaminating proteins.
Chromatography was carried out in either denaturing or nondenaturing
conditions. Denatured proteins were refolded using different dialysis
protocols (addition of PEG 8000, 0.1% Triton X-100, enzyme diluted to
50 µg/ml, dialysis at room temperature), however, none of these
yielded enzymes with high specific activity (data not shown). The yield and specific activity of the different enzymes are shown in Table I. CALPB prepared from the soluble
fraction has the highest specific activity (similar to that of
recombinant m-calpain). Renatured CALPB is less active, indicating the
lack of perfect refolding. CALPA has the lowest specific activity
probably due to imperfect refolding (similarly to renatured CALPB).
However, the specific activity of CALPA-
Ins is also low suggesting
that the low activity of CALPA is not only due to the
denaturation-renaturation procedure but also is intrinsic to CALPA. The
low specific activity of CALPA and CALPA-
Ins could be increased
4-5-fold by the addition of certain phospholipids (see below).
Specific activity and yield of recombinant calpains
Ins, 4.38 ± 0.63 mM for renatured CALPB, and
3.28 ± 0.46 mM for soluble CALPB. Given that the
soluble forms have millimolar Ca2+ need as well, it is
unlikely that only renaturation is responsible for the unusually high
values. Ba2+, Mg2+, Cu2+, and
Ni2+ ions did not activate either CALPA or CALPB, however,
CALPB, but not CALPA, was slightly activated by Mn2+ ions
(data not shown).

View larger version (12K):
[in a new window]
Fig. 4.
Ca2+-activation curve of
recombinant CALPA (A) and CALPB
(B). The activity was measured in a caseinolytic
assay as described under "Experimental Procedures." The
Ca2+ activation curve of renatured CALPA and CALPB is
shown.
Ins, and CALPB in the
presence of calcium. Autolysis of CALPA-
Ins and CALPB resulted in a
single, 81-kDa product, while multiple autolytic products of different
lengths were generated from CALPA. CALPA-
Ins could not be fully
autolyzed, because of its parallel degradation, which led to the
enzyme's disappearance upon longer incubation times. The difference in
the autolytic products of CALPA and CALPA-
Ins is very likely due to
the differences in the preparation procedures. CALPA is prepared from
inclusion bodies, and has lower specific activity, probably due to
partially misfolded proteins in the preparation which fraction could be
degraded in an aspecific manner, giving multiple bands on the SDS gel.
Multiple autolytic fragments were also observed when renatured CALPB
was analyzed (data not shown).

View larger version (26K):
[in a new window]
Fig. 5.
Autolysis of CALPA (A),
CALPA-
Ins (B), and CALPB
(C). The enzymes were incubated in the presence
of 10 mM Ca2+ at 24 °C for the times
indicated above the lanes. Since autolysis and activation of
CALPA and CALPA-
Ins was very slow in the absence of phospholipids,
these proteins were autolyzed in the presence of 50 µg/ml
PIP2. The autolytic conversion of CALPA-
Ins and CALPB
into one 81-kDa fragment contrasts the heterogeneous autolytic profile
of CALPA. The two lower molecular weight bands in the CALPA-
Ins
sample are not autolytic products but contaminating proteins present in
the original preparation. No autolysis was observed in the absence of
Ca2+ (not shown).
Ins and CALPB was N-terminal
sequenced after electrophoresis and blotting, giving the sequence NMRVL
and NMFW for CALPA-
Ins and CALPB, respectively. Self-cleavage was
thus shown to have occurred between Lys54-Asn55
in CALPA-
Ins and between Gln90-Asn91 in
CALPB (Fig. 1). The cleavage sites are at identical positions, 88 (CALPA-
Ins) and 89 (CALPB) amino acids N-terminal from the active
site Cys. Interestingly, the second cleavage site of mammalian µ-calpain before Leu28 (giving the 76-kDa active form
(22)) is 87 amino acids from Cys, whereas m-calpain is cleaved before
Ser20, i.e. 85 amino acids from Cys (23). This
conservation of the autolytic site suggests a common evolutionary
origin and the ancient nature of the self-regulation of calpain by autolysis.
Ins were not studied in this
respect because of their imperfect autolysis.
Ins,
and CALPB was studied in a fluorometric assay. The continuous
monitoring of the cleavage of a fluorogenic substrate allowed detailed
kinetic analyses. After the addition of calcium activity continuously
increased until it reached a plateau of maximal activity. As seen in
Fig. 6 there is a lag phase which
corresponds to activation. The fluorometric progress curves were
differentiated to better visualize the activation period (Fig.
7). The enzymes are thus inactive at the
beginning of the reaction, and become progressively activated as the
reaction proceeds.

View larger version (14K):
[in a new window]
Fig. 6.
Fluorometric measurement of calpain
activity. Progress curves of soluble CALPB in the presence of 1, 5, and 10 mM free Ca2+. The lag phase is
clearly observable. The linear phase of the curves was extrapolated to
zero substrate conversion (dashed lines) to determine the
transit time of activation. Renatured CALPB was activated similarly,
although its specific activity was lower (not shown).

View larger version (14K):
[in a new window]
Fig. 7.
Activation of CALPA (A),
CALPA-
Ins (B), and CALPB
(C). CALPA (A) and CALPB
(C) activation is shown in the presence of increasing
amounts of Ca2+, that of CALPA-
Ins (B) in the
presence of PIP2, phosphatidic acid, or PI (20 mM Ca2+). To plot calpain activity as a
function of time, the fluorometric progress curves (Fig. 6) were
differentiated. The transit time of CALPA activation is much longer
(note the different time scale). 100% represents the activity of the
enzyme saturated with Ca2+ (for CALPA-
Ins maximal
activity in the presence of PIP2 and 20 mM
Ca2+).

View larger version (16K):
[in a new window]
Fig. 8.
Autolysis parallels activation of CALPB.
Activation is represented by the differentiated fluorometric progress
curves, while autolysis is shown as the percentage of full-length, 91 kDa (
) and autolyzed, 81-kDa (
) forms as determined by
densitometry. Free Ca2+ concentration was 1 mM
(A), 10 mM (B), and 50 mM
(C). 100% activity is the enzymes maximal activity at the
given Ca2+ concentration.

View larger version (16K):
[in a new window]
Fig. 9.
The disappearance of the activation phase in
the autolyzed, 81-kDa CALPB form. The 81-kDa CALPB form was
assayed in the fluorometric test (see "Experimental Procedures") in
the presence of 1, 5, 10, and 20 mM free Ca2+.
Dashed lines indicate the linear fit. No activation period
can be observed on the progress curves (compare with Fig. 6). To
generate the 81-kDa fragment, CALPB was incubated in the presence of 50 mM Ca2+ for 1 min at room temperature. The
reaction was stopped with EDTA and the autolyzed sample was dialyzed
against calpain buffer overnight. The completion of autolysis was
checked by SDS-polyacrylamide gel electrophoresis.
Ins, since these enzymes underwent only imperfect autolysis and were gradually degraded. However, based on the identical cleavage site in CALPA-
Ins and CALPB and the similar kinetics of activation, we propose that CALPA is also activated through N-terminal autolytic processing.
Ins
were greatly enhanced by the addition of certain phospholipids (Fig.
10). PIP2, PIP, PI, and
phosphatidic acid increased the activation rate constant and the
maximal rate of the hydrolysis of the fluorescent substrate.
Phosphatidylethanolamine and phosphatidylcholine had only minor
effects. The only difference that could be observed between CALPA and
CALPA-
Ins was the much greater increase of the activation rate
constant of CALPA in the presence of PIP2 and phosphatidic
acid. In contrast to CALPA and CALPA-
Ins, soluble and renatured
CALPB could barely be activated by these phospholipids. PIP2 enhanced CALPB activity 2-fold and PA increased the
rate of CALPB autolysis 4-fold, but the latter had no effect on the activity of the fully activated enzyme. To see whether phospholipids alter the Ca2+ sensitivity of CALPA, the caseinolytic
activity of the enzyme was determined in the presence of either PIP or
phosphatidic acid and varying amounts of calcium. Neither of these
lipids altered significantly the Ca2+ concentration needed
for half-maximal activity (2.23 ± 0.28 and 2.08 ± 0.03, respectively).

View larger version (25K):
[in a new window]
Fig. 10.
The effect of various phospholipids
(A) on the activation rate constant and
(B) the activity of CALPA (black),
CALPA-
Ins (white), and CALPB
(gray). Activation rate constant (1/s) is the first-order rate
constant of activation and equals the reciprocal of transit time (see
Fig. 6). Activity was determined from the plateau of the differentiated
fluorometric progress curves (see Fig. 7). The fluorometric assay was
set up in a final volume of 50 µl, in the presence of 20 mM Ca2+ and 50 µg/ml lipid. Protein
concentration was between 0.1 and 0.3 mg/ml. Activity was taken as
100% in the absence of lipids (Control).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Ins were isolated from the
soluble fraction as reported for recombinant rat m-calpain (20,
27).
Ins and
CALPB also required Ca2+ in the millimolar range. The
in vivo Ca2+ concentrations, however, are at
least an order of magnitude lower than those in the present assays,
which raises concerns about the physiological significance of the
results. Vertebrate calpains become sensitized to calcium either upon
phospholipid binding (39), through autolysis, dissociation, or upon
binding to an activator protein (40-42). Autolysis and phospholipids
had minor effect on the Ca2+ requirement of CALPB and
CALPA, respectively, arguing for the existence of other regulatory
factors, potentially similar to the vertebrate activator proteins.
Ins was affected similarly, moreover, the
behavior of renatured and soluble CALPB was also indistinguishable.
Ins.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Institute of
Enzymology, Biological Research Center, Hungarian Academy of Sciences. H-1518 Budapest, P. O. Box 7, Hungary. Tel.: 361-466-5633; Fax: 361-466-5465; E-mail: jekely@enzim.hu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Molinari, M.,
and Carafoli, E.
(1997)
J. Membr. Biol.
156,
1-8[CrossRef][Medline]
[Order article via Infotrieve]
2.
Carafoli, E.,
and Molinari, M.
(1998)
Biochem. Biophys. Res. Commun.
247,
193-203[CrossRef][Medline]
[Order article via Infotrieve]
3.
Gitler, D.,
and Spira, M. E.
(1998)
Neuron
20,
1123-35[CrossRef][Medline]
[Order article via Infotrieve]
4.
Richard, I.,
Broux, O.,
Allamand, V.,
Fougerousse, F.,
Chiannilkulchai, N.,
Bourg, N.,
Brenguier, L.,
Devaud, C.,
Pasturaud, P.,
Roudaut, C.,
Hillaire, D.,
Passos-Bueno, M.,
Zatz, M.,
Tischfield, J. A.,
Fardeau, M.,
Jacksn, C. E.,
Cohen, D.,
and Beckmann, J. S.
(1995)
Cell
81,
27-40[CrossRef][Medline]
[Order article via Infotrieve]
5.
Emori, Y.,
and Saigo, K.
(1994)
J. Biol. Chem.
269,
25137-25142 6.
Aszódi, A.,
Müller, U.,
Friedrich, P.,
and Spatz, H. C.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
5832-5836 7.
Sorimachi, H.,
and Suzuki, K.
(1992)
Biochim. Biophys. Acta
1160,
55-62[CrossRef][Medline]
[Order article via Infotrieve]
8.
Sorimachi, H.,
Ishiura, S.,
and Suzuki, K.
(1993)
J. Biol. Chem.
268,
19476-82 9.
Lee, H. J.,
Sorimachi, H.,
Jeong, S. Y.,
Ishiura, S.,
and Suzuki, K.
(1998)
Biol. Chem.
379,
175-83[Medline]
[Order article via Infotrieve]
10.
Andresen, K.,
Tom, T. D.,
and Strand, M.
(1991)
J. Biol. Chem.
266,
15085-15090 11.
Karcz, S. R.,
Podesta, R. B.,
Siddiqui, A. A.,
Dekaban, G. A.,
Strejan, G. H.,
and Clarke, M. W.
(1991)
Mol. Biochem. Parasitol.
49,
333-336[CrossRef][Medline]
[Order article via Infotrieve]
12.
Barnes, T. M.,
and Hodgkin, J.
(1996)
EMBO J.
15,
4477-4484[Medline]
[Order article via Infotrieve]
13.
Theopold, U.,
Pintér, M.,
Daffre, S.,
Tryselius, Y.,
Friedrich, P.,
Nassel, D. R.,
and Hultmark, D.
(1995)
Mol. Cell. Biol.
15,
824-834[Abstract]
14.
The C. elegans Sequencing Consortium.
(1998)
Science
282,
2012-2018 15.
Pintér, M.,
and Friedrich, P.
(1988)
Biochem. J.
253,
467-473[Medline]
[Order article via Infotrieve]
16.
Pintér, M.,
Stierandova, A.,
and Friedrich, P.
(1992)
Biochemistry
31,
8201-8206[CrossRef][Medline]
[Order article via Infotrieve]
17.
Jékely, G., and Friedrich, P. (1999) J. Mol. Evol., in
press
18.
Amano, S.,
Kawasaki, H.,
Ishiura, S.,
Kawashima, S.,
Suzuki, K.,
and Emori, Y.
(1997)
J. Biochem. (Tokyo)
122,
865-871 19.
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
20.
Elce, J. S.,
Hegadorn, C.,
Gauthier, S.,
Vince, J. W.,
and Davies, P. L.
(1995)
Protein Eng.
8,
843-848 21.
Lennon, G.,
Auffray, C.,
Polymeropoulos, M.,
and Soares, M. B.
(1996)
Genomics
33,
151-152[CrossRef][Medline]
[Order article via Infotrieve]
22.
Zimmerman, U. J.,
and Schlaepfer, W. W.
(1991)
Biochim. Biophys. Acta
1080,
275[CrossRef][Medline]
[Order article via Infotrieve]
23.
Brown, N.,
and Crawford, C.
(1993)
FEBS Lett.
322,
65-68[CrossRef][Medline]
[Order article via Infotrieve]
24.
Edmunds, T.,
Nagainis, P. A.,
Sathe, S. K.,
Thompson, V. F.,
and Goll, D. E.
(1991)
Biochim. Biophys. Acta
1077,
197-208[CrossRef][Medline]
[Order article via Infotrieve]
25.
Frieden, C.
(1979)
Annu. Rev. Biochem.
48,
471-89[CrossRef][Medline]
[Order article via Infotrieve]
26.
Vilei, E. M.,
Calderara, S.,
Anagli, J.,
Berardi, S.,
Hitomi, K.,
Maki, M.,
and Carafoli, E.
(1997)
J. Biol. Chem.
272,
25802-25808 27.
Graham-Siegenthaler, K.,
Gauthier, S.,
Davies, P. L.,
and Elce, J. S.
(1994)
J. Biol. Chem.
269,
30457-30460 28.
Suzuki, K.
(1987)
Trends Biochem. Sci.
12,
103-105[CrossRef]
29.
Johnson, G. V.,
and Guttmann, R. P.
(1997)
Bioessays
19,
1011-1018[CrossRef][Medline]
[Order article via Infotrieve]
30.
Suzuki, K.,
and Sorimachi, H.
(1998)
FEBS Lett.
433,
1-4[CrossRef][Medline]
[Order article via Infotrieve]
31.
Suzuki, K.,
Tsuji, S.,
Ishiura, S.,
Kimura, Y.,
Kubota, S.,
and Imahori, K.
(1981)
J. Biochem. (Tokyo)
90,
1787-1793 32.
Baki, A.,
Tompa, P.,
Alexa, A.,
Molnar, O.,
and Friedrich, P.
(1996)
Biochem. J.
318,
897-901
33.
Molinari, M.,
Anagli, J.,
and Carafoli, E.
(1994)
J. Biol. Chem.
269,
27992-27995 34.
Elce, J. S.,
Hegadorn, C.,
and Arthur, J. S. C.
(1997)
J. Biol. Chem.
272,
11268-11275 35.
Pontremoli, S.,
Salamino, F.,
Sparatore, B.,
Michetti, M.,
Sacco, O.,
and Melloni, E.
(1985)
Biochim. Biophys. Acta
831,
335-339[CrossRef][Medline]
[Order article via Infotrieve]
36.
Michetti, M.,
Salamino, F.,
Tedesco, I.,
Averna, M.,
Minafra, R.,
Melloni, E.,
and Pontremoli, S.
(1996)
FEBS Lett.
392,
11-15[CrossRef][Medline]
[Order article via Infotrieve]
37.
Schoenwaelder, S. M.,
Kulkarni, S.,
Salem, H. H.,
Imajoh-Ohmi, S.,
Yamao-Harigaya, W.,
Saido, T. C.,
and Jackson, S. P.
(1997)
J. Biol. Chem.
272,
24876-24884 38.
Yoshizawa, T.,
Sorimachi, H.,
Tomioka, S.,
Ishiura, S.,
and Suzuki, K.
(1995)
Biochem. Biophys. Res. Commun.
208,
376-383[CrossRef][Medline]
[Order article via Infotrieve]
39.
Saido, T. C.,
Shibata, M.,
Takenawa, T.,
Murofushi, H.,
and Suzuki, K.
(1992)
J. Biol. Chem.
267,
24585-24590 40.
Pontremoli, S.,
Melloni, E.,
Michetti, M.,
Salamino, F.,
Sparatore, B.,
and Horecker, B. L.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
1740-1743 41.
Pontremoli, S.,
Viotti, P. L.,
Michetti, M.,
Sparatore, B.,
Salamino, F.,
and Melloni, E.
(1990)
Biochem. Biophys. Res. Commun.
171,
569-574[CrossRef][Medline]
[Order article via Infotrieve]
42.
Michetti, M.,
Viotti, P. L.,
Melloni, E.,
and Pontremoli, S.
(1991)
Eur. J. Biochem.
202,
1177-1180[Medline]
[Order article via Infotrieve]
43.
Pontremoli, S.,
Melloni, E.,
Sparatore, B.,
Salamino, F.,
Michetti, M.,
Sacco, O.,
and Horecker, B. L.
(1985)
Biochem. Biophys. Res. Commun.
128,
331-338[CrossRef][Medline]
[Order article via Infotrieve]
44.
Felsenstein, J.
(1993)
PHYLIP (Phylogeny Inference Package), Version 3.5c
, Felsenstein, J., Department of Genetics, University of Washington, Seattle
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. W. Park and Y. Emori Drosophila Calpain B is Monomeric and Autolyzes Intramolecularly J. Biochem., February 1, 2008; 143(2): 217 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Kim, E. S. Chang, and D. L. Mykles Three calpains and ecdysone receptor in the land crab Gecarcinus lateralis: sequences, expression and effects of elevated ecdysteroid induced by eyestalk ablation J. Exp. Biol., August 15, 2005; 208(16): 3177 - 3197. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tompa, P. Buzder-Lantos, A. Tantos, A. Farkas, A. Szilagyi, Z. Banoczi, F. Hudecz, and P. Friedrich On the Sequential Determinants of Calpain Cleavage J. Biol. Chem., May 14, 2004; 279(20): 20775 - 20785. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alexa, Z. Bozoky, A. Farkas, P. Tompa, and P. Friedrich Contribution of Distinct Structural Elements to Activation of Calpain by Ca2+ Ions J. Biol. Chem., May 7, 2004; 279(19): 20118 - 20126. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. GOLL, V. F. THOMPSON, H. LI, W. WEI, and J. CONG The Calpain System Physiol Rev, July 1, 2003; 83(3): 731 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yu an |